Loading...
Loading...
Savient Pharmaceuticals,
Inc.
SVNT today announced the appointment of John P. Hamill as
Senior Vice President & Chief Financial Officer effective today. Mr. Hamill
brings over 25 years of global financial and administrative operational
experience to Savient with a specialized background in pharmaceutical service
industry. Mr. Hamill will be responsible for all financial and accounting
functions of the Company and will report directly to Lou Ferrari, President
and Chief Executive Officer of Savient.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in